An adult male with a recent ingrown fingernail removal that drained pus now has increased pain and redness; what cephalexin (Keflex) regimen should be prescribed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Dosing for Infected Ingrown Fingernail

Prescribe cephalexin 500 mg orally every 6 hours (four times daily) for 7-10 days for this infected surgical site/wound infection.

Rationale and Clinical Approach

This patient has a surgical site infection following ingrown nail removal with purulent drainage, now presenting with worsening pain and erythema. This represents a skin and soft tissue infection (SSTI) requiring systemic antibiotics in addition to any drainage that occurred.

Why Systemic Antibiotics Are Indicated

The IDSA guidelines specify that adjunctive systemic antimicrobial therapy should be used for surgical site infections associated with significant systemic response, including erythema and induration extending >5 cm from the wound edge 1. While your patient may not meet all severe criteria, the progression despite drainage (increased pain and redness after pus drainage yesterday) indicates active infection requiring treatment.

Importantly, research specifically addressing ingrown toenails found that antibiotics don't accelerate healing when given with definitive surgical management 2. However, your patient already had the nail removed yesterday and is now worsening—this is a post-procedure infection, not a pre-procedure scenario, making antibiotics appropriate.

Specific Dosing Recommendation

For surgical site infections of the trunk or extremity away from axilla/perineum, the IDSA guidelines list cephalexin 500 mg every 6 hours orally as an appropriate regimen 1. The FDA label confirms the adult dosage ranges from 1-4 g daily in divided doses, with 500 mg every 12 hours approved for skin and skin structure infections, though noting that "for more severe infections or those caused by less susceptible organisms, larger doses may be needed" 3.

Given the progression despite drainage, I recommend the higher frequency dosing:

  • Cephalexin 500 mg orally every 6 hours (QID) for 7-10 days

This provides 2 g daily, which optimizes PK/PD parameters for moderate infections, particularly those caused by Staphylococcus aureus (the most likely pathogen in this setting) 4.

Alternative Dosing Consideration

If compliance is a concern, 500 mg every 12 hours (BID) is FDA-approved for skin infections 3 and has demonstrated efficacy in clinical trials 5, 6. However, the BID dosing may be suboptimal for infections showing progression, as higher doses optimize pharmacodynamic targets 4.

Duration

7-10 days is appropriate. The IDSA guidelines don't specify exact duration for surgical site infections, but the FDA label indicates skin infections typically require this timeframe 3. Monitor clinical response at 48-72 hours—if significantly improved, complete the full course; if worsening, consider MRSA coverage or alternative diagnosis.

Critical Pitfalls to Avoid

  • Don't underdose: The common 250 mg QID regimen may be insufficient for established infection with progression
  • Ensure adequate drainage: If there's an undrained abscess or collection, antibiotics alone will fail—consider re-evaluation for additional I&D
  • Watch for MRSA: If the patient fails to improve in 48-72 hours, consider community-acquired MRSA and switch to trimethoprim-sulfamethoxazole, doxycycline, or clindamycin 1
  • Assess for deeper infection: Increased pain could indicate deeper soft tissue involvement, osteomyelitis (if bone was exposed), or necrotizing infection (though unlikely in this presentation)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.